Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Influence of Raltegravir-Containing Antiretroviral Therapy (ART) on Immune Reconstitution and Activation in the Female Genital Tract

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT01456962
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:36:32.946995+00:00
Published At
2015-06-12T00:00:00+00:00
Record Updated At
2017-06-09
Results Posted At
2015-06-12
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Women\u0027s Health", "HIV Infection", "Genital Diseases, Female"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2017-06-09"
protocolSection.identificationModule.nctId
"NCT01456962"
protocolSection.identificationModule.officialTitle
"Influence of Raltegravir-Containing Antiretroviral Therapy (ART) on Immune Reconstitution and Activation in the Female Genital Tract"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
[]
protocolSection.statusModule.resultsFirstPostDateStruct.date
"2015-06-12"

Study condition terms

  • Women's Health (protocolSection.conditionsModule.conditions)
  • HIV Infection (protocolSection.conditionsModule.conditions)
  • Genital Diseases, Female (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.